Vienna, Austria

Zvonko Milicevic

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Eli Lilly and Company. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zvonko Milicevic. Retrieved from https://idiyas.com/inventor/zvonko-milicevic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Zvonko Milicevic: Innovator in Pharmaceutical Compositions

Introduction

Zvonko Milicevic is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new dosing methods for medications.

Latest Patents

Milicevic holds a patent for "Methods of using and compositions containing dulaglutide." This invention relates to innovative methods of utilizing higher doses of dulaglutide and the compositions that incorporate these new doses. His work aims to enhance the efficacy of this medication, which is crucial for treating various medical conditions.

Career Highlights

Zvonko Milicevic is associated with Eli Lilly and Company, a leading global pharmaceutical company. His role at Eli Lilly has allowed him to focus on groundbreaking research and development in the pharmaceutical sector. His expertise and innovative approach have contributed to the advancement of medical treatments.

Collaborations

Milicevic has collaborated with esteemed colleagues, including David Andrew Cox and Lai San Tham. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.

Conclusion

Zvonko Milicevic is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact patient care. His innovative methods and collaborations reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…